Estrogen receptors (ERs), progesterone receptors (PRs) and human epidermal growth factor receptor 2 (HER2/neu or HER2) are established, essential predictive markers in breast cancer which help to choose systematic therapy. This evidence concerns the gene PGR and breast cancer.